NatureWise Biotech & Medicals Corporation (TPEX:4732)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.50
-0.50 (-2.50%)
At close: Mar 9, 2026
-15.03%
Market Cap 916.55M
Revenue (ttm) 180.29M
Net Income (ttm) -37.01M
Shares Out 47.00M
EPS (ttm) -0.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 45,246
Average Volume 19,886
Open 20.00
Previous Close 20.00
Day's Range 19.40 - 20.10
52-Week Range 17.40 - 27.85
Beta 0.68
RSI 43.08
Earnings Date Mar 30, 2026

About TPEX:4732

NatureWise Biotech & Medicals Corporation engages in the research and development of Western medicine, Chinese medicine, and biotechnology in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; and green propolis and red yeast rice products. The company was founded in 1990 and is headquartered in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1990
Employees 31
Stock Exchange Taipei Exchange
Ticker Symbol 4732
Full Company Profile

Financial Performance

In 2024, TPEX:4732's revenue was 224.32 million, an increase of 40.08% compared to the previous year's 160.14 million. Earnings were 897,000, a decrease of -91.14%.

Financial Statements

News

There is no news available yet.